Updates
Stay informed on recent developments in the world of biomarkers for bladder cancer surveillance
Alternating cystoscopy with a urinary marker for the surveillance of intermediate-risk NMIBC
Watch the clinical case discussion by Prof. Dr. Paolo Gontero to learn more about the advantages of alternating cystoscopy with a urinary marker for the surveillance of intermediate-risk non-muscle-invasive bladder cancer (NMIBC). Prof. Dr. Paolo Gontero is Professor...
Compare your opinion with peers and Mr. Hugh Mostafid
True or false? The sensitivity and negative predictive value for detecting high-grade UTUC* is higher with Bladder EpiCheck compared to cytology. Submit your answer and read the opinion of Mr. Hugh Mostafid * Upper tract urothelial carcinomaShare this on...
New EAU 2022 guidelines: Urinary biomarkers for the surveillance of NMIBC
Watch the editorial comment by Prof. Dr. Paolo Gontero on biomarker statements in the new EAU 2022 guidelines. Prof. Dr. Paolo Gontero is Professor of Urology at the University of Turin School of Medicine and Chairmen of the Division of Urology at the San Giovanni...
Hey, it is bladder cancer awareness month in May!
The World Bladder Cancer Patient Coalition hosts this special month to highlight the facts about bladder cancer, promote awareness of the disease and call for more investment in research, treatment and care. The theme of this year’s edition “Don’t Go Red. Go To A...
How to improve conventional cystoscopy for bladder cancer diagnosis and follow-up?
Watch the case presentation of Dr. Ekaterina Laukhtina (Moscow, Russia) At the 19th Meeting of the EAU Section of Oncological Urology (ESOU22), held on 21-23 January 2022 in Madrid, Spain, Dr. Ekaterina Laukhtina presented a case with non-muscle invasive bladder...
Why urinary biomarkers should be used for the surveillance of non-muscle-invasive bladder cancer
Clinical case presentation by Dr. Ekaterina Laukhtina (Moscow, Russia) Editorial comment by Morgan Rouprêt The implementation and advantages of urinary biomarkers for non-muscle-invasive-bladder (NMIBC) were discussed by an international expert panel at the 19th...
Compare your opinion with peers and Prof. Dr. Morgan Rouprêt
Miranda, 81 years old, resides in a retirement home. To fill her day, she knits woollen scarves and hats for her fellow residents. Two years ago, she underwent TURBT of 1 small papillary tumour of 1 cm at the right bladder wall, which was detected during a cystoscopic...
Compare your opinion with peers and Prof. Dr. Marek Babjuk
According to the EAU 2022 guidelines, Bladder EpiCheck, Cxbladder Monitor, ADXBLADDER, Xpert Bladder Cancer Monitor might be used to replace and/or postpone cystoscopy in the surveillance of Submit your answer and read the opinion of Prof. Dr. Marek Babjuk...
Alternating cystoscopy with a urinary marker for the surveillance of intermediate-risk NMIBC
Watch the clinical case discussion by Prof. Dr. Paolo Gontero to learn more about the advantages of alternating cystoscopy with a urinary marker for the surveillance of intermediate-risk non-muscle-invasive bladder cancer (NMIBC). Prof. Dr. Paolo Gontero is Professor...
Compare your opinion with peers and Mr. Hugh Mostafid
True or false? The sensitivity and negative predictive value for detecting high-grade UTUC* is higher with Bladder EpiCheck compared to cytology. Submit your answer and read the opinion of Mr. Hugh Mostafid * Upper tract urothelial carcinomaShare this on...